Trident Lifeline Limited (BOM:543616)
India · Delayed Price · Currency is INR 407.70
+28.55 (7.53%)
At close: Sep 25, 2026
Trident Lifeline Market Cap
Trident Lifeline has a market cap or net worth of 4.87 billion as of September 25, 2026. Its market cap has increased by 44.59% in one year.
Market Cap
4.87B
Enterprise Value
5.63B
Revenue
1.39B
Ranking
n/a
PE Ratio
22.77
Stock Price
407.70
ChartMarket Cap Chart
Since October 10, 2022, Trident Lifeline's market cap has increased from 1.24B to 4.87B, an increase of 291.20%. That is a compound annual growth rate of 41.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.87B | 31.22% |
| Dec 31, 2025 | 3.71B | 15.15% |
| Dec 30, 2024 | 3.22B | 48.94% |
| Dec 29, 2023 | 2.16B | 51.61% |
| Dec 30, 2022 | 1.43B | 14.66% |
| Oct 10, 2022 | 1.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 7.60B |
| ZIM Laboratories | 7.53B |
| Albert David | 4.97B |
| Jenburkt Pharmaceuticals | 4.22B |
| Medicamen Biotech | 4.19B |
| Astonea Labs | 3.50B |
| Ambalal Sarabhai Enterprises | 3.15B |
| BDH Industries | 2.85B |